Jujube leaf green tea extracts inhibits hepatocellular carcinoma cells by activating AMPK

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Hepatocellular carcinoma (HCC) remains a significant global health challenge with limited effective treatments.
• Natural compounds are increasingly investigated for their therapeutic potential against various cancers.
• Jujube leaf green tea extracts (JLGTE) represent a novel area of research for anti-cancer applications.

Purpose of the Study:

• To evaluate the anti-hepatocellular carcinoma (HCC) activity of Jujube leaf green tea extracts (JLGTE).
• To elucidate the molecular mechanisms underlying JLGTE's anti-cancer effects, focusing on AMP-activated protein kinase (AMPK) signaling.
• To determine the specificity of JLGTE's action on cancer cells versus normal hepatocytes.

Main Methods:

• In vitro assays using HepG2 and primary human HCC cells, as well as normal hepatocytes.
• Assessment of JLGTE's effects on cell proliferation, cytotoxicity, and apoptosis.
• Molecular studies involving AMPK signaling pathway activation, including gene silencing (shRNA, CRISPR-Cas9) and dominant-negative/constitutively-active AMPKα1 mutants.

Main Results:

• JLGTE demonstrated significant anti-proliferative, cytotoxic, and pro-apoptotic effects specifically against HCC cells.
• JLGTE exhibited no cytotoxicity towards normal hepatocytes, indicating selective action.
• Activation of the AMPK signaling pathway was identified as a crucial mediator of JLGTE's anti-cancer activity.
• Inhibition or activation of AMPK directly modulated JLGTE's cytotoxic and pro-apoptotic effects on HCC cells.

Conclusions:

• JLGTE possesses significant potential as a therapeutic agent against hepatocellular carcinoma.
• The anti-cancer efficacy of JLGTE is primarily mediated through the activation of the AMPK signaling pathway.
• JLGTE's selective toxicity towards cancer cells suggests a promising therapeutic index for future development.